Arsenic trioxide induces apoptosis in peripheral blood T lymphocyte subsets by inducing oxidative stress: a role of Bcl-2.

Arsenic trioxide (As(2)O(3)) has been used successfully in the treatment of acute promyelocytic leukemia. However, effects of As(2)O(3) in normal peripheral blood T cells have not been studied in detail. The purpose of this study was to investigate whether As(2)O(3) would induce apoptosis in normal T cells and therefore may have immunosuppressive side effects. Apoptosis was measured by terminal deoxynucleotidyl transferase-mediated nick end labeling assay, caspase activation by flow cytometry and colorimetric assay, mitochondrial transmembrane potential (deltapsi(m)), intracellular reactive oxygen species (ROS), and intracellular reduced glutathione (GSH) by flow cytometry. The release of cytochrome c and apoptosis-inducing factor (AIF) from the mitochondria was measured by confocal microscopy, and the expression of molecules regulating apoptosis was measured by Western blotting. As(2)O(3), at clinically achievable therapeutic concentrations, induces apoptosis in peripheral blood T cells. As(2)O(3)-induced apoptosis was associated with reduced deltapsi(m), enhanced generation of intracellular ROS, decreased levels of intracellular GSH, release of cytochrome c and AIF from the mitochondria, activation of caspases, down-regulation of Bcl-2 and Bcl-x(L), and up-regulation of Bax expression. In addition, exogenous GSH protected lymphocytes from As(2)O(3)-induced apoptosis. Furthermore, overexpression of Bcl-2 inhibited As(2)O(3)-induced apoptosis and blocked depolarization of deltapsi(m), generation of ROS, and release of both cytochrome c and AIF. These data indicate that As(2)O(3) induces apoptosis in T cells by enhancing oxidative stress and that Bcl-2 appears to play a major role in As(2)O(3)-induced apoptosis.

[1]  Mason R. Mackey,et al.  Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane , 2002, Cell.

[2]  Gwo-Shing Chen,et al.  Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis , 2002 .

[3]  S. Makani,et al.  Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: a major role of mitochondrial pathway , 2002, Genes and Immunity.

[4]  Dean P. Jones,et al.  Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in HL60 cells that overexpress Bcl‐2 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  C. Rhee,et al.  Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. , 2002, International journal of oncology.

[6]  S. Grimm,et al.  The permeability transition pore signals apoptosis by directing Bax translocation and multimerization , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Y. Akao,et al.  Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. , 2002, Biochemical and biophysical research communications.

[8]  S. Korsmeyer,et al.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.

[9]  T. Mak,et al.  Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.

[10]  G. Kroemer,et al.  Dominant cell death induction by extramitochondrially targeted apoptosis‐inducing factor , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[12]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[13]  E. White,et al.  TNF-alpha signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. , 2000, Molecular cell.

[14]  Z. Meng,et al.  Effects of arsenic on blast transformation and DNA synthesis of human blood lymphocytes. , 2000, Chemosphere.

[15]  G. Wu,et al.  As2O3 induces apoptosis of the human B lymphoma cell line MBC-1. , 2000, Journal of biological regulators and homeostatic agents.

[16]  J. Martinou,et al.  Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane , 2000, Molecular and Cellular Biology.

[17]  John Calvin Reed,et al.  Endogenous Inhibitors of Caspases , 1999, Journal of Clinical Immunology.

[18]  L. Ghibelli,et al.  Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  P. Zhang.  The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. , 1999, Journal of biological regulators and homeostatic agents.

[20]  G. Kroemer,et al.  Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. , 1999, Experimental cell research.

[21]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[22]  P. Ostrosky-Wegman,et al.  Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of interleukin-2. , 1999, Immunopharmacology and immunotoxicology.

[23]  J. Larghero,et al.  Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. , 1999, Cancer research.

[24]  D. Green,et al.  Bax-induced Caspase Activation and Apoptosis via Cytochromec Release from Mitochondria Is Inhibitable by Bcl-xL* , 1999, The Journal of Biological Chemistry.

[25]  P. Pandolfi,et al.  Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide , 2001 .

[26]  Jen-kun Lin,et al.  Involvement of reactive oxygen species and caspase 3 activation in arsenite‐induced apoptosis , 1998, Journal of cellular physiology.

[27]  Y. Akao,et al.  Arsenic induces apoptosis in B‐cell leukaemic cell lines in vitro: activation of caspases and down‐regulation of Bcl‐2 protein , 1998, British journal of haematology.

[28]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[29]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[30]  G. Kroemer,et al.  The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins , 1998, The Journal of experimental medicine.

[31]  C. Colussi,et al.  Rescue of cells from apoptosis by inhibition of active GSH extrusion , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  B. Mignotte,et al.  Mitochondria and apoptosis. , 1998, European journal of biochemistry.

[33]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[34]  B. Chernyak,et al.  Modulation of the Mitochondrial Permeability Transition Pore by Pyridine Nucleotides and Dithiol Oxidation at Two Separate Sites (*) , 1996, The Journal of Biological Chemistry.

[35]  P. Waring,et al.  A decrease in intracellular glutathione concentration precedes the onset of apoptosis in murine thymocytes. , 1995, European journal of cell biology.

[36]  G. Kroemer,et al.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death , 1995, The Journal of experimental medicine.

[37]  L. Scorrano,et al.  The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. , 1994, The Journal of biological chemistry.

[38]  D. Hedley,et al.  Evaluation of methods for measuring cellular glutathione content using flow cytometry. , 1994, Cytometry.

[39]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[40]  M. Zoratti,et al.  Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. , 1992, The Journal of biological chemistry.

[41]  M. Brand,et al.  CONTROL OF ELECTRON FLUX THROUGH THE RESPIRATORY CHAIN IN MITOCHONDRIA AND CELLS , 1987, Biological reviews of the Cambridge Philosophical Society.

[42]  Sudhir Gupta,et al.  Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). , 2003, International journal of oncology.

[43]  S. Shi.  Use of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia , 2002 .

[44]  G. Kroemer,et al.  The mitochondrion in apoptosis: how Pandora's box opens , 2001, Nature Reviews Molecular Cell Biology.

[45]  T. Naoe,et al.  In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. , 1996, Blood.

[46]  T. Buttke,et al.  Oxidative stress as a mediator of apoptosis. , 1994, Immunology today.

[47]  B. P. Yu,et al.  Cellular defenses against damage from reactive oxygen species. , 1994, Physiological reviews.